JNJ Stock Slides As Company Loses Landmark Opioid Case
Johnson & Johnson (NYSE:JNJ) has lost a landmark case regarding its role in the opioid crisis, causing further losses for JNJ stock. An Oklahoma judge has ordered the pharmaceutical heavyweight to pay $572 million USD ... [Read]
CELG Stock is Up 45% YTD: What Should You Know?
CELG stock is currently on a good run of good news in 2019 after a few years of bad news from Celgene Corporation (NASDAQ:CELG). In May, the company secured US Food and Drug Administration approval ... [Read]
Mylan Stock Drops 8.5% After US Lawmakers Slam MYL
Mylan stock has dropped 8.5% today after Mylan (NASDAQ:MYL) was slammed by two prominent US lawmakers. Coordinated Obstruction The company, along with two other major pharmaceuticals, is being investigated as part of an ongoing probe ... [Read]
Amgen Stock Continues to Rise Following Court Ruling
Amgen stock (NASDAQ:AMGN) continued its positive run today, gaining 4.9% after the judge upheld two of the firm’s key patents. On Friday, a New Jersey judge ruled in Amgen’s favor in a dispute with Novartis (NYSE:NVS) ... [Read]
ACAD Stock Slumps to 5-Month Low on Schizophrenia Setback
ACAD stock is taking a major hit today, slumping to a new 5-month low after Acadia Pharmaceuticals Inc (NASDAQ:ACAD)’s schizophrenia treatment did not pass a late-stage clinical trial. Disappointing News Clinical trials are extremely important ... [Read]
ILMN Stock Falls 15%: Illumina Spooks Investors by Slashing Earnings
ILMN stock is taking a major hit in Friday’s trading session after the DNA sequencing company Illumina, Inc. (NASDAQ:ILMN) stated that its Q2 2019 revenue will miss projections because of challenges with its direct-to-consumer genomic ... [Read]
AMRN Stock Rockets 13% As Amarin Sees Strong Revenues
AMRN has been on a tear on Tuesday and has gone up by as much as 13% as Amarin Corporation plc (NASDAQ:AMRN) raised its projections for the company’s revenues for the year 2019. Revenue Projection ... [Read]
BMY Stock Drops 7% After Delaying Acquisition of Celgene Corporation
Similar to cannabis stocks, Bristol-Myers Squibb (NYSE:BMY) has not had a solid start to the week, and neither has Celgene Corporation (NASDAQ:CELG). These two, however, have something to do with one another. On news that ... [Read]
ARRY Stock Hits All-Time High on Pfizer’s Acquisition
ARRY stock is witnessing a solid day after Pfizer Inc (NYSE:PFE) announced it was acquiring Array Biopharma Inc (NASDAQ:ARRY). 62% Premium on ARRY Stock In a significant development, pharmaceutical giant Pfizer has decided to acquire ... [Read]
CVS Stock Jumps On Plans to Expand a New Store Format
CVS stock is leading the healthcare sector higher after CVS Health Corp (NYSE:CVS) revealed a range of major new offerings at its stores. Expanding Strategy Access to quality healthcare is one of the most important ... [Read]